Father Georgia's Story
After a months-long battle with liver and kidney disease, Father John Georgia, the pastor of the Church of Resurrection in Wallingford, was restored to health after a liver and kidney transplant at Yale-New Haven Hospital. He and his doctors relate his experience.
Any transplant program can claim to be the best. But when it comes to measuring how good a transplantation center is, data speaks louder than words. According to the Scientific Registry of Transplant Recipients, a national database of organ transplantation statistics:
- The adult patient one-year survival rate for liver transplants at YNHTC is 89 percent
- The pediatric patient one-year survival rate for liver transplants at YNHTC is 100 percent
- The adult patient one-year survival rate for kidney transplants at YNHTC is 98 percent
- The pediatric patient one-year survival rate for kidney transplants at YNHTC is 100 percent
These superior outcomes are the result of an uncompromising commitment to provide patients who have end-stage organ failure with state-of-the-art, compassionate care; and restore them to health through innovative surgical and medical procedures. The hallmarks of our program are clinical excellence, passionate patient care and research in organ failure for adult and pediatric patients.
Our team approach
At YNHTC, team members include transplant surgeons, hepatologists, nephrologists, nurses, pharmacists, financial coordinators, nutritionists, social workers, business associates, and even answering service staff who may take calls from concerned patients and families in the middle of the night. This approach has been shown to provide the best experiences and outcomes for patients.
YNHTC team members perform liver, kidney, kidney/pancreas, pancreas and heart transplantation. The center is the region's leader in the evaluation and treatment of advanced liver disease. In addition, we provide vascular access for patients who require dialysis treatment. YNHTC offers innovative treatments and access to research trials for patients suffering from a wide range of conditions, including kidney failure, liver failure and Type 1 diabetes mellitus.
YNHTC provides options and hope for high-risk patients who have been turned down for transplantation elsewhere. Innovations in surgery include living donor, split, reduced and mono-segment liver transplantation.
Patients who have end-stage kidney disease, complications from diabetes, or both may be referred to YNHTC for transplant evaluation. Our well-established program, in existence since 1967, offers traditional transplantation of the kidney donated from a deceased donor as well as living-donor transplantation.
The Hepatobiliary Cancer Program offers an entire spectrum of therapies for liver cancer, also known as hepatobiliary carcinoma. A combination of interventional radiology and surgical techniques, including ablation therapy, liver resection, new chemotherapeutic options and liver transplantation, are now available; and in certain patients, these treatments can even cure the disease.
YNHTC serves patients from Connecticut, New York, New Jersey, throughout the country and beyond. We are a major referral center for other transplant programs faced with particularly challenging cases. We communicate with our patients on regular basis so that we can monitor their progress with the transplanted organ.